Skip to main content
SpringerPlus

Table 2 Patient clinical characteristics

From: Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate

 

TEL

PLA

Patients evaluated

25

24

Male/female

6/19

6/18

Age, years: mean ± SD (range) 59 ± 14 (27–78)

52.9 ± 9

53 ± 10

Alive

23

21

Dead

2

3

Tumor type

TEL

PLA

Breast

8

10

Endometrium

12

9

Non-Hodgkin’s lymphoma

1

2

NSCLC

0

1

Ovary

4

1

Salivary gland

0

1

Stage

TEL

PLA

   I

14

13

   II

6

7

   III

4

3

   IV

1

1

ECOG/PS

TEL

PLA

  0

18

15

  1

6

4

  2

1

5

  1. Abbreviations. ECOG PS: Eastern Cooperative Oncology Group performance status; NSCLC: non-small cell lung cancer.
Back to article page